Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05940402
What this trial is testing

Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function

Who this might be right for
Renal Impairment
AbbVie 58
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Large-scale testing (Phase 3)Active Not RecruitingNCT06592586
What this trial is testing

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Who this might be right for
Streptococcus Agalactiae InfectionNeonatal SepsisPneumonia+6 more
Minervax ApS 137
Early research (Phase 1)Looking for participantsNCT05065372
What this trial is testing

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesDiabetic Kidney DiseaseCardiovascular Diseases+2 more
Kalie Tommerdahl 60
Early research (Phase 1)Study completedNCT07032272
What this trial is testing

Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.

Who this might be right for
Autoimmune and Chronic Inflammatory Diseases
Novartis Pharmaceuticals 16
Not applicableStudy completedNCT02723305
What this trial is testing

Cardiometabolic Profiles of Boys With Klinefelter Syndrome

Who this might be right for
Klinefelter Syndrome47,XXYSex Chromosome Aneuploidy+1 more
University of Colorado, Denver 31
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Post-approval studies (Phase 4)UnknownNCT01897831
What this trial is testing

Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

Who this might be right for
Respiratory Tract InfectionsUrinary Tract Infections
Xiangbei Welman Pharmaceutical Co., Ltd 2,000
Early research (Phase 1)Study completedNCT02266394
What this trial is testing

Hypoxia and Inflammatory Injury in Human Renovascular Hypertension

Who this might be right for
Renal Artery StenosisIschemic NephropathyRenovascular Disease+1 more
Mayo Clinic 42
Early research (Phase 1)Study completedNCT01148095
What this trial is testing

To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers

Who this might be right for
Part A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years.Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80
AstraZeneca 6
Early research (Phase 1)Ended earlyNCT05226507
What this trial is testing

Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Who this might be right for
Advanced Solid TumorOvarian CancerOvarian Clear Cell Carcinoma+5 more
Nuvectis Pharma, Inc. 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT02397083
What this trial is testing

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
M.D. Anderson Cancer Center 102
Post-approval studies (Phase 4)Study completedNCT02344602
What this trial is testing

The Effect of Uric Acid Lowering in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University Health Network, Toronto 73
Early research (Phase 1)Ended earlyNCT01906307
What this trial is testing

LJPC-501 in Patients With Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome Type I and Type II
La Jolla Pharmaceutical Company 6
Testing effectiveness (Phase 2)Study completedNCT00003539
What this trial is testing

Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 50
Early research (Phase 1)Study completedNCT04348175
What this trial is testing

Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment

Who this might be right for
Renal Insufficiency
Rhythm Pharmaceuticals, Inc. 32
Not applicableLooking for participantsNCT05650619
What this trial is testing

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more
University of Michigan 300
Large-scale testing (Phase 3)Looking for participantsNCT07044336
What this trial is testing

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Who this might be right for
Endometrial CancerMalignant Solid Tumour
AstraZeneca 800
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Next Page